ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 125 filers reported holding ACORDA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.30 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $275,000 | -64.4% | 95,845 | -4.9% | 0.00% | -66.7% |
Q2 2019 | $773,000 | -49.4% | 100,745 | -12.4% | 0.01% | -45.5% |
Q1 2019 | $1,529,000 | -10.7% | 115,052 | +4.7% | 0.01% | -15.4% |
Q4 2018 | $1,712,000 | +3.7% | 109,907 | +30.8% | 0.01% | +18.2% |
Q3 2018 | $1,651,000 | -15.8% | 84,028 | +23.0% | 0.01% | -15.4% |
Q2 2018 | $1,960,000 | +31.6% | 68,306 | +8.5% | 0.01% | +8.3% |
Q1 2018 | $1,489,000 | +34.0% | 62,973 | +21.6% | 0.01% | +50.0% |
Q4 2017 | $1,111,000 | +2.2% | 51,801 | +12.7% | 0.01% | 0.0% |
Q3 2017 | $1,087,000 | +31.0% | 45,944 | +9.1% | 0.01% | +33.3% |
Q2 2017 | $830,000 | -1.0% | 42,115 | +5.5% | 0.01% | 0.0% |
Q1 2017 | $838,000 | +0.6% | 39,925 | -9.9% | 0.01% | 0.0% |
Q4 2016 | $833,000 | -32.2% | 44,313 | -24.7% | 0.01% | -40.0% |
Q3 2016 | $1,228,000 | -25.6% | 58,819 | -9.1% | 0.01% | -33.3% |
Q2 2016 | $1,651,000 | +21.3% | 64,714 | +25.8% | 0.02% | +7.1% |
Q1 2016 | $1,361,000 | -44.0% | 51,450 | -9.5% | 0.01% | -41.7% |
Q4 2015 | $2,432,000 | -86.3% | 56,850 | -15.2% | 0.02% | +26.3% |
Q3 2015 | $17,779,000 | +1155.6% | 67,065 | +57.8% | 0.02% | +58.3% |
Q2 2015 | $1,416,000 | +101.7% | 42,496 | +101.4% | 0.01% | +100.0% |
Q1 2015 | $702,000 | – | 21,097 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
IFP Advisors, Inc | 0 | $0 | 0.00% |
JNBA Financial Advisors | 1 | $0 | 0.00% |